Advanced search
Publication Cover
Pharmacogenomics and Personalized Medicine Volume 8, 2015 - Issue
Submit an article Journal homepage
332
Views
18
CrossRef citations to date
0
Altmetric
Review

Economic evaluations of personalized medicine: existing challenges and current developments

Fatiha H Shabaruddin1 Department of Pharmacy, University of Malaya, Kuala Lumpur, MalaysiaCorrespondence[email protected]
,
Nigel D Fleeman2 Liverpool Reviews and Implementation Group (LRiG), University of Liverpool, Liverpool, UK
&
Katherine Payne3 Institute of Population Health, The University of Manchester, Manchester, UK
Pages 115-126 | Published online: 24 Jun 2015

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Giuseppe Miscio, Giulia Paroni, Paola Bisceglia, Carolina Gravina, Maria Urbano, Madia Lozupone, Carla Piccininni, Michele Prisciandaro, Grazia Ciavarella, Antonio Daniele, Antonello Bellomo, Francesco Panza, Lazzaro Di Mauro, Antonio Greco & Davide Seripa. (2019) Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline. Expert Opinion on Drug Metabolism & Toxicology 15:9, pages 751-765.
Read now
John Lally, Fiona Gaughran, Philip Timms & Sarah R Curran. (2016) Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics. Pharmacogenomics and Personalized Medicine 9, pages 117-129.
Read now

Articles from other publishers (16)

Jean Paul Muambangu Milambo, Peter S Nyasulu, John M Akudugu & James Ndirangu. (2023) Long-term effects of aromatase inhibitors on body mass index among postmenopausal breast cancer survivors in Africa: observational cohort study. BMC Research Notes 16:1.
Crossref
Roberto Piergentili, Giuseppe Basile, Cristina Nocella, Roberto Carnevale, Enrico Marinelli, Renato Patrone & Simona Zaami. (2022) Using ncRNAs as Tools in Cancer Diagnosis and Treatment—The Way towards Personalized Medicine to Improve Patients’ Health. International Journal of Molecular Sciences 23:16, pages 9353.
Crossref
Jovany Cruz Navarro, Lucido L. Ponce Mejia & Claudia Robertson. (2022) A Precision Medicine Agenda in Traumatic Brain Injury. Frontiers in Pharmacology 13.
Crossref
Mikyung Kelly Seo & Mark Strong. (2021) A Practical Guide to Modeling and Conducting a Cost-Effectiveness Analysis of Companion Biomarker Tests for Targeted Therapies Using R: Tutorial Paper. PharmacoEconomics 39:12, pages 1373-1381.
Crossref
Zahra Ghasemi, Saeid Safari & Alireza Zali. (2021) Role of Pharmacoeconomics in Precision Medicine. Precision Medicine and Clinical OMICS 1:1.
Crossref
Louisa G. Gordon, Nicole M. White, Thomas M. Elliott, Katia Nones, Anthony G. Beckhouse, Astrid J. Rodriguez-Acevedo, Penelope M. Webb, Xing J. Lee, Nicholas Graves & Deborah J. Schofield. (2020) Estimating the costs of genomic sequencing in cancer control. BMC Health Services Research 20:1.
Crossref
Miriam Kasztura, Aude Richard, Nefti-Eboni Bempong, Dejan Loncar & Antoine Flahault. (2019) Cost-effectiveness of precision medicine: a scoping review. International Journal of Public Health 64:9, pages 1261-1271.
Crossref
James Love-Koh, Alison Peel, Juan Carlos Rejon-Parrilla, Kate Ennis, Rosemary Lovett, Andrea Manca, Anastasia Chalkidou, Hannah Wood & Matthew Taylor. (2018) The Future of Precision Medicine: Potential Impacts for Health Technology Assessment. PharmacoEconomics 36:12, pages 1439-1451.
Crossref
Gerard Harty, James Jarrett & Mireia Jofre-Bonet. (2018) Consequences of Biomarker Analysis on the Cost-Effectiveness of Cetuximab in Combination with FOLFIRI as a First-Line Treatment of Metastatic Colorectal Cancer: Personalised Medicine at Work. Applied Health Economics and Health Policy 16:4, pages 515-525.
Crossref
Katherine Payne, Sean P. Gavan, Stuart J. Wright & Alexander J. Thompson. (2018) Cost-effectiveness analyses of genetic and genomic diagnostic tests. Nature Reviews Genetics 19:4, pages 235-246.
Crossref
Susan R. Snyder, Jing Hao, Larisa H. Cavallari, Zhi Geng, Amanda Elsey, Julie A. Johnson, Zahurin Mohamed, Nathorn Chaiyakunapruk, Huey Yi Chong, Maznah Dahlui, Fatiha H. Shabaruddin, George P. Patrinos, Christina Mitropoulou & Marc S. Williams. (2018) Generic Cost-Effectiveness Models: A Proof of Concept of a Tool for Informed Decision-Making for Public Health Precision Medicine. Public Health Genomics 21:5-6, pages 217-227.
Crossref
N. S. Munung, B. M. Mayosi & J. de Vries. (2018) Genomics research in Africa and its impact on global health: insights from African researchers. Global Health, Epidemiology and Genomics 3.
Crossref
M Verbelen, M E Weale & C M Lewis. (2017) Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?. The Pharmacogenomics Journal 17:5, pages 395-402.
Crossref
John S. Morrison & Michael J. Hageman. 2017. Translating Molecules into Medicines. Translating Molecules into Medicines 421 447 .
Hans-Joerg Fugel, Mark Nuijten, Maarten Postma & Ken Redekop. (2016) Economic Evaluation in Stratified Medicine: Methodological Issues and Challenges. Frontiers in Pharmacology 7.
Crossref
Gerardo Jimenez-Sanchez. (2015) Genomics innovation: transforming healthcare, business, and the global economy. Genome 58:12, pages 511-517.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.